George C Eckert Ii

Array ( [id] => 11263495 [patent_doc_number] => 09487780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-08 [patent_title] => 'Antisense compounds targeting genes associated with fibronectin' [patent_app_type] => utility [patent_app_number] => 14/403953 [patent_app_country] => US [patent_app_date] => 2013-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 35904 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10057513 [patent_doc_number] => 09096858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response' [patent_app_type] => utility [patent_app_number] => 13/905242 [patent_app_country] => US [patent_app_date] => 2013-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 10 [patent_no_of_words] => 15018 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13905242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9455251 [patent_doc_number] => 08716259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Oligonucleotide chelate complexes' [patent_app_type] => utility [patent_app_number] => 13/905318 [patent_app_country] => US [patent_app_date] => 2013-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 52 [patent_no_of_words] => 16738 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13905318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710833 [patent_doc_number] => 08835401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Treatment of cancer by inhibition of IGFBPs and clusterin' [patent_app_type] => utility [patent_app_number] => 13/904457 [patent_app_country] => US [patent_app_date] => 2013-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 6242 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13904457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9055328 [patent_doc_number] => 20130253042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'Oligonucleotide Conjugates' [patent_app_type] => utility [patent_app_number] => 13/892065 [patent_app_country] => US [patent_app_date] => 2013-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12923 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13892065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9537164 [patent_doc_number] => 20140161811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'PLATELET DERIVED GROWTH FACTOR RECEPTOR SUPPORTS CYTOMEGALOVIRUS INFECTIVITY' [patent_app_type] => utility [patent_app_number] => 13/887244 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15130 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13887244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10353514 [patent_doc_number] => 20150238515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 14/397815 [patent_app_country] => US [patent_app_date] => 2013-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 222333 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11575950 [patent_doc_number] => 09631193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'Compositions and methods for inhibiting expression of the ALAS1 gene' [patent_app_type] => utility [patent_app_number] => 14/391392 [patent_app_country] => US [patent_app_date] => 2013-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 83258 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14391392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8951282 [patent_doc_number] => 20130197063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'USE OF A GROWTH-STIMULATING PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/849210 [patent_app_country] => US [patent_app_date] => 2013-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11850 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13849210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10095854 [patent_doc_number] => 09132148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Gene silencing by single-stranded polynucleotides' [patent_app_type] => utility [patent_app_number] => 13/848249 [patent_app_country] => US [patent_app_date] => 2013-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20262 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10069570 [patent_doc_number] => 09107904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => 'Immunostimulatory compositions and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/844075 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 40 [patent_no_of_words] => 21330 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13844075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9739152 [patent_doc_number] => 20140274872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'COMPOSITIONS AND TREATMENTS BASED ON CADHERIN MODULATION' [patent_app_type] => utility [patent_app_number] => 13/844553 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 38344 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13844553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9737228 [patent_doc_number] => 20140272946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'Methods and Systems For DNA-Based Detection And Reporting' [patent_app_type] => utility [patent_app_number] => 13/833538 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4848 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13833538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9538443 [patent_doc_number] => 20140163090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS' [patent_app_type] => utility [patent_app_number] => 13/841711 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24597 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13841711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10097160 [patent_doc_number] => 09133461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Compositions and methods for inhibiting expression of the ALAS1 gene' [patent_app_type] => utility [patent_app_number] => 13/835613 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 79117 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13835613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9739489 [patent_doc_number] => 20140275207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'ANTISENSE COMPOUNDS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/804846 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20900 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13804846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10090505 [patent_doc_number] => 09127320 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'miR-193a-3p and associated genes predict tumorigenesis and chemotherapy outcomes' [patent_app_type] => utility [patent_app_number] => 13/829903 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20742 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13829903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9107588 [patent_doc_number] => 20130280720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'TISSUE BIOMARKERS FOR INDICATION OF PROGRESSION FROM BARRETT\'S ESOPHAGUS TO ESOPHAGEAL ADENOCARCINOMA' [patent_app_type] => utility [patent_app_number] => 13/798932 [patent_app_country] => US [patent_app_date] => 2013-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12350 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13798932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9917919 [patent_doc_number] => 20150073124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'micro-RNA INHIBITOR' [patent_app_type] => utility [patent_app_number] => 14/383043 [patent_app_country] => US [patent_app_date] => 2013-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20284 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14383043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9034330 [patent_doc_number] => 20130236967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'Modifications for Antisense Compounds' [patent_app_type] => utility [patent_app_number] => 13/776397 [patent_app_country] => US [patent_app_date] => 2013-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 28976 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13776397 [rel_patent_id] =>[rel_patent_doc_number] =>)